AeroRx Therapeutics
PrivateLast Round
Series A
Oct 7, 2025
Total Funding Raised
$27M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AeroRx Therapeutics is a biotechnology company that develops proprietary, nebulized combination drug therapies for the treatment of chronic respiratory diseases such as chronic obstructive pulmonary disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AeroRx Therapeutics Comparables
Compare AeroRx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merck & Co., Inc. | 76% | |
| Sumitomo Pharma Co., Ltd. | 72% | |
| Theravance Biopharma Inc | 72% |
AeroRx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 7, 2025 | ||||
| Seed | Apr 1, 2024 |
AeroRx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alexandria Venture Investments | Series A |
| Avalon BioVentures | Series A |
| Correlation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
$21M round completed.
AeroRx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AeroRx Therapeutics's valuation, stock price, and market status.
Is AeroRx Therapeutics a public or private company?
AeroRx Therapeutics is a private company.
What is the current stock price of AeroRx Therapeutics?
AeroRx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is AeroRx Therapeutics worth (valuation)?
Valuation information for AeroRx Therapeutics is not publicly available.
Can I buy AeroRx Therapeutics stock?
AeroRx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AeroRx Therapeutics's last funding round?
AeroRx Therapeutics's most recent funding round was Series A on October 7, 2025.
Who are the main investors in AeroRx Therapeutics?
Key investors in AeroRx Therapeutics include Avalon BioVentures.
Will AeroRx Therapeutics IPO soon?
No public IPO plans have been announced for AeroRx Therapeutics.
How can I track AeroRx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AeroRx Therapeutics's secondary market activity and sign up for updates.